Fig. 2From: Quercetin and Cisplatin combined treatment altered cell cycle and mitogen activated protein kinase expressions in malignant mesotelioma cellsmRNA levels of JNK/SAPK and p38MAPK pathway members. Cells treated with 50 μM QU and 50 μM QU + 5 μg/ml CIS. Two-fold or more differences compared to control cells were evaluated by RT2-PCR array Group 1: DMSO Control versus Quercetin; Group 2: DMSO control versus Quercetin + CisplatinBack to article page